Cardiff-based CatSci Ltd has won the coveted Queen’s Award For Enterprise: International Trade 2022.
The Queen’s Award for Enterprise is one of the most prestigious awards in the UK, and winning this accolade is a huge achievement for Welsh business.
Established in 2011, CatSci now works with four of the world’s top five pharmaceutical companies, employs nearly 100 people and had sales of over £5.8m in 2021. They have 6 operational labs on two British sites equipped with the latest high-end products. equipment. From their headquarters in Cardiff, they have done business in 13 countries and recently announced their expansion into Japan, the second largest market for pharmaceutical innovation.
Winning the Queen’s Award recognizes the hard work, talent and commitment of the entire CatSci team.
Dr Mark Waring, our Director of UK Operations and Cardiff Site, said:
I am immensely proud that CatSci has received this fantastic recognition. It is a well-deserved reward for the hard work and talent of our incredible team who have continued to serve our customers around the world during these most difficult times. We are all driven by a common mission to create cutting-edge, perfectly matched therapeutic products that will meet the global healthcare needs of patients.
As a team, we are committed to continually evolving to support pharmaceutical companies around the world and meet their CMC demands, so they can meet patient needs. Since the origin of CatSci, we have always been passionate about bringing much-needed therapies to the
hands of patients around the world. To make this vision a reality, we have focused our efforts on developing our capabilities, our facilities and our team of experts. By placing such emphasis on our exponential evolution, we are able to always offer more and better to our global customers.
Winning the Queen’s Award for Enterprise is a huge honor for CatSci. This prestigious distinction reflects CatSci’s innovative export strategy and cutting-edge scientific expertise, and reinforces our position as a dynamic, agile and world-class innovation partner for drug development. We are proud to put Wales on the international pharmaceutical industry map.